Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOVA School-Age Follow-up
NCT00152542Phase 3Completed
- Sponsor
- University of Chicago
- Start
- May 2005
- Primary completion
- Sep 2006
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nitric oxide in respiratory distress syndrome (RDS) and hypoxemia, sponsored by University of Chicago. Primary endpoint: School-readiness. Started May 2005; status: completed.
02
Drugs
nitric oxide
03
Conditions
respiratory distress syndrome (RDS)hypoxemia
Beyond the preview
Go deeper on NCT00152542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152542.